DHV Digital Health Ventures

DHV Digital Health Ventures is a Berlin-based, sector-focused early-stage venture capital fund founded in 2015 by Ulli Jendrik Koop, dedicated to building a sustainable digital health ecosystem across Europe. The firm is managed by DHV Management GmbH and invests in young startups pioneering human-centric healthcare solutions primarily in Germany and other European markets, with additional activity in Scandinavia, Canada, and the US. DHV leads rounds and writes checks from $250,000 to $5 million across pre-seed through Series B stages, with approximately 10 investments and two exits to date. Portfolio companies include TeleClinic (telemedicine, acquired by Zur Rose Group in 2020), Wefight (chronic illness virtual assistant, for which DHV led an $11.8 million Series A), Liva Healthcare (digital chronic disease management used by NHS England), DrugStars (medicine review and donation platform), and Movn Health. Managing Partners Ulli Jendrik Koop, Guido Hegener (an early-stage digital health investor since 2013), and Min-Sung Sean Kim (formerly at Allianz X and Samsung Catalyst Fund) lead the investment team. DHV's investment thesis prioritizes digital health startups with attractive business models that leverage technology to improve patient outcomes. The firm draws on a strong network of experienced investors, clinicians, and healthcare operators, positioning it as more than a capital source — portfolio companies gain access to clinical validation pathways and commercial partnerships that are critical for scaling health technology businesses.